| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
TOTAL COSTS AND OPERATING EXPENSES | ||||||
Research and development | ||||||
6,794 | 6,514 | 7,174 | 5,677 | 4,527 | 3,962 | |
General and administrative | ||||||
13,281 | 7,007 | 9,232 | 4,265 | 3,867 | 1,011 | |
Sales and marketing | ||||||
2,164 | 1,681 | 2,443 | 1,198 | 324 | - | |
Total costs and operating expenses | ||||||
22,239 | 15,202 | 18,849 | 11,140 | 8,718 | 4,973 | |
Loss from operations | ||||||
-22,239 | -15,202 | -18,849 | -11,140 | -8,718 | -4,973 | |
OTHER INCOME (EXPENSES), NET | ||||||
Loss on extinguishment of debt | ||||||
-153 | - | - | - | - | - | |
Interest income (expense), net | ||||||
- | - | - | -28 | -19 | - | |
Interest expense, net | ||||||
299 | -216 | -217 | - | - | -2 | |
Unrealized gain (loss) on marketable equity securities | ||||||
-49 | -427 | - | - | - | - | |
Pro rata loss from equity method investment in Razor | ||||||
-281 | - | - | - | - | - | |
Loss on sale of available-for-sale securities and other expenses, net | ||||||
- | - | - | 0 | 0 | - | |
Other income (expenses), net | ||||||
-3 | 91 | -309 | 0 | 2 | -11 | |
Total other income (expenses), net | ||||||
-187 | -552 | -526 | -28 | -17 | -13 | |
NET LOSS | ||||||
-22,426 | -15,754 | -19,375 | -11,168 | -8,735 | -4,986 | |
Net loss per share; basic and diluted | ||||||
-0.44 | -0.42 | -0.64 | -0.42 | -0.42 | -0.27 | |
Weighted average shares outstanding; basic and diluted | ||||||
51,296 | 37,850 | 30,195 | 26,529 | 21,009 | 18,200 | |